- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/58 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 215/58
Total number of patents in this class: 96
10-year publication summary
|
8
|
9
|
6
|
8
|
7
|
7
|
10
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zydus Lifesciences Limited | 136 |
10 |
| Stemsynergy Therapeutics, Inc. | 21 |
6 |
| Bristol-myers Squibb Company | 4729 |
4 |
| The Regents of the University of Michigan | 4979 |
4 |
| Merck Sharp & Dohme LLC | 3735 |
4 |
| Cadila Healthcare Limited | 294 |
3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 774 |
3 |
| Lycera Corporation | 31 |
3 |
| Pfizer Inc. | 3384 |
2 |
| FUJIFILM Corporation | 30512 |
2 |
| Northwestern University | 3540 |
2 |
| Korea Research Institute of Chemical Technology | 1469 |
2 |
| National Cancer Center | 339 |
2 |
| Ono Pharmaceutical Co., Ltd. | 422 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 870 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
2 |
| Nanjing Gear Pharma & Tech Co., Ltd. | 3 |
2 |
| University of Hong Kong Versitech Limited | 13 |
2 |
| F. Hoffmann-La Roche AG | 7836 |
1 |
| The Regents of the University of California | 20720 |
1 |
| Other owners | 37 |